Romina P. Pardo

Av. 25 De Mayo 1021, Buenos Aires 1650
General San Martin, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Hantavirus GnH Nanoparticle Immunogen Elicits a Cross-Neutralizing Antibody Response in Mice.

Hantavirus GnH Nanoparticle Immunogen Elicits a Cross-Neutralizing Antibody Response in Mice.

Journal: ACS infectious diseases

Published: October 13, 2025

Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA YOLK) administered by parenteral or mucosal routes against Brucella ovis in rams.

Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA YOLK) administered by parenteral or mucosal routes against Brucella ovis in rams.

Journal: Veterinary immunology and immunopathology

Published: July 10, 2025

INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome.

INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome.

Journal: Toxins

Published: March 29, 2025

Cryo-EM structures of engineered Shiga toxin-based immunogens capable of eliciting neutralizing antibodies with therapeutic potential against hemolytic uremic syndrome.

Cryo-EM structures of engineered Shiga toxin-based immunogens capable of eliciting neutralizing antibodies with therapeutic potential against hemolytic uremic syndrome.

Journal: Protein science : a publication of the Protein Society

Published: December 26, 2024

Development of a hyperimmune equine serum therapy for COVID-19 in Argentina.

Development of a hyperimmune equine serum therapy for COVID-19 in Argentina.

Journal: Medicina

Published: July 14, 2020

Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice.

Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice.

Journal: Research in veterinary science

Published: May 25, 2020

Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein.

Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein.

Journal: Journal for immunotherapy of cancer

Published: March 05, 2020

Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.

Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.

Journal: Journal of clinical microbiology

Published: September 23, 2019

Characterization of folding-sensitive nanobodies as tools to study the expression and quality of protein particle immunogens.

Characterization of folding-sensitive nanobodies as tools to study the expression and quality of protein particle immunogens.

Journal: Journal of biotechnology

Published: July 10, 2018

Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against Brucella ovis in rams.

Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against Brucella ovis in rams.

Journal: Veterinary immunology and immunopathology

Published: June 02, 2018

Development of a product anti-Shiga toxin for prevention of the hemolytic uremic syndrome

Development of a product anti-Shiga toxin for prevention of the hemolytic uremic syndrome

Journal: Medicina

Published: April 17, 2018

Polymeric antigen BLSOmp31 in aluminium hydroxide induces serum bactericidal and opsonic antibodies against Brucella canis in dogs.

Polymeric antigen BLSOmp31 in aluminium hydroxide induces serum bactericidal and opsonic antibodies against Brucella canis in dogs.

Journal: Veterinary immunology and immunopathology

Published: May 13, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026